Concentric Capital Strategies LP Takes $12.52 Million Position in Maximus, Inc. $MMS

Concentric Capital Strategies LP purchased a new stake in shares of Maximus, Inc. (NYSE:MMS) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 145,014 shares of the health services provider’s stock, valued at approximately $12,518,000. Concentric Capital Strategies LP owned 0.27% of Maximus as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. increased its position in shares of Maximus by 19.8% during the third quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock valued at $18,304,000 after buying an additional 33,136 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Maximus by 2.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after purchasing an additional 36,989 shares during the last quarter. Divisadero Street Capital Management LP increased its position in shares of Maximus by 93.5% in the third quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock worth $16,800,000 after purchasing an additional 88,872 shares during the last quarter. WINTON GROUP Ltd bought a new position in shares of Maximus in the third quarter worth approximately $6,208,000. Finally, Assenagon Asset Management S.A. bought a new position in shares of Maximus in the fourth quarter worth approximately $15,673,000. 97.21% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Finally, Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Maximus Stock Down 2.7%

Shares of NYSE MMS opened at $59.52 on Thursday. Maximus, Inc. has a one year low of $56.92 and a one year high of $100.00. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.21 and a quick ratio of 2.21. The firm’s 50 day simple moving average is $63.33 and its two-hundred day simple moving average is $75.32. The stock has a market capitalization of $3.13 billion, a P/E ratio of 8.91 and a beta of 0.58.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same period last year, the business earned $2.01 earnings per share. The business’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, analysts expect that Maximus, Inc. will post 8.43 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Friday, May 15th. Maximus’s dividend payout ratio (DPR) is presently 19.76%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.